Literature DB >> 6749282

B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease.

P J Martin, V Najfeld, P J Fialkow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749282     DOI: 10.1016/0165-4608(82)90092-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


× No keyword cloud information.
  6 in total

1.  Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia.

Authors:  Sureyya Bozkurt; Burak Uz; Yahya Buyukasik; Ozlen Bektas; Ayten Inanc; Hakan Goker; Emin Kansu
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

2.  Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.

Authors:  J B Konopka; S Clark; J McLaughlin; M Nitta; Y Kato; A Strife; B Clarkson; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

Authors:  J C Young; O N Witte
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

4.  Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope.

Authors:  S Seremetis; J Cuttner; R Winchester
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

Authors:  J McLaughlin; E Chianese; O N Witte
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

Authors:  A G Elefanty; I K Hariharan; S Cory
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.